• AlzeCure publishes its Year-end report for January – December 2022

  • AlzeCure participates at Redeye Alzheimer Seminar on March 15

  • AlzeCure achieves Last Patient Last Visit (LPLV) in its phase II clinical trial of the non-opioid ACD440 in neuropathic pain

AlzeCure Pharma

AlzeCure Pharma is a Swedish pharmaceutical company focusing on the research and development of innovative and efficacious treatments for Alzheimer’s disease and related disorders


AlzeCure is developing disease modifying and symptomatic first in class treatments for Alzheimer’s disease and other conditions characterized by cognitive dysfunction

Alzheimer’s Disease

Alzheimer’s disease is a deadly disorder which lacks effective treatments. The need for novel treatments is therefore urgent.